孟德尔随机化研究:体重指数与银屑病存在因果关联
该研究基于已发表的流行病学证据,利用97个BMI相关SNP作为工具变量,在英国生物银行(396495人)和挪威HUNT队列(个体数据)及已发表GWAS汇总数据(356926人)中开展单样本和双样本孟德尔随机化分析。结果显示,BMI每增加1 kg/m2,银屑病 odds 增加9%(OR=1.09,95%CI 1.06-1.12,P=4.67×10^-9),而银屑病遗传风险对BMI无显著因果效应。结论支持较高BMI因果性增加银屑病风险。
要点
- 观察性数据显示银屑病患者BMI平均较对照高1.26 kg/m2(成人)和1.55 kg/m2(儿童)。
- 孟德尔随机化证实BMI每升高1 kg/m2,银屑病风险增加9%。
- 银屑病遗传风险对BMI无显著因果效应,支持BMI→银屑病的单向因果方向。
核心结论
- 孟德尔随机化分析提供证据表明较高的BMI因果性增加银屑病风险。
- 未发现银屑病遗传风险对BMI有因果效应。
研究设计与样本
- 采用孟德尔随机化设计,以97个BMI相关SNP作为工具变量。
- 单样本MR使用英国生物银行和挪威HUNT研究的个体数据(共396495人)。
- 双样本MR使用已发表的BMI和银屑病GWAS汇总数据(356926人)。
- 采用固定效应模型对单样本和双样本MR估计进行荟萃分析。
- 同时进行反向MR分析,以银屑病遗传变异为工具变量检验其对BMI的因果效应。
主要发现
- 观察性数据显示成人银屑病病例与对照的BMI平均差异为1.26 kg/m2(95%CI 1.02-1.51),儿童为1.55 kg/m2(95%CI 1.13-1.98)。
- 荟萃分析显示BMI每增加1 kg/m2,银屑病 odds 增加4%(OR=1.04,95%CI 1.03-1.04,P=1.73×10^-60)。
- MR分析显示BMI每增加1 kg/m2,银屑病 odds 增加9%(OR=1.09,95%CI 1.06-1.12,P=4.67×10^-9)。
- 反向MR分析未支持银屑病遗传风险对BMI有因果效应(每doubling odds of psoriasis的BMI变化为0.004 kg/m2,95%CI -0.003至0.011)。
临床怎么用
- 研究结果支持将控制体重作为预防或治疗银屑病的优先干预措施。
- 临床可考虑对银屑病患者进行体重管理以改善疾病风险。
局限性
- 银屑病可能存在患者自我报告错误或临床医生误诊。
- 研究队列的种族多样性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Psoriasis is a common inflammatory skin disease that has been reported to be associated with obesity. We aimed to investigate a possible causal relationship between body mass index (BMI) and psoriasis. METHODS AND FINDINGS: Following a review of published epidemiological evidence of the association between obesity and psoriasis, mendelian randomization (MR) was used to test for a causal relationship with BMI. We used a genetic instrument comprising 97 single-nucleotide polymorphisms (SNPs) associated with BMI as a proxy for BMI (expected to be much less confounded than measured BMI). One-sample MR was conducted using individual-level data (396,495 individuals) from the UK Biobank and the Nord-Trøndelag Health Study (HUNT), Norway. Two-sample MR was performed with summary-level data (356,926 individuals) from published BMI and psoriasis genome-wide association studies (GWASs). The one-sample and two-sample MR estimates were meta-analysed using a fixed-effect model. To test for a potential reverse causal effect, MR analysis with genetic instruments comprising variants from recent genome-wide analyses for psoriasis were used to test whether genetic risk for this skin disease has a causal effect on BMI. Published observational data showed an association of higher BMI with psoriasis. A mean difference in BMI of 1.26 kg/m2 (95% CI 1.02-1.51) between psoriasis cases and controls was observed in adults, while a 1.55 kg/m2 mean difference (95% CI 1.13-1.98) was observed in children. The observational association was confirmed in UK Biobank and HUNT data sets. Overall, a 1 kg/m2 increase in BMI was associated with 4% higher odds of psoriasis (meta-analysis odds ratio [OR] = 1.04; 95% CI 1.03-1.04; P = 1.73 × 10(-60)). MR analyses provided evidence that higher BMI causally increases the odds of psoriasis (by 9% per 1 unit increase in BMI; OR = 1.09 (1.06-1.12) per 1 kg/m2; P = 4.67 × 10(-9)). In contrast, MR estimates gave little support to a possible causal effect of psoriasis genetic risk on BMI (0.004 kg/m2 change in BMI per doubling odds of psoriasis (-0.003 to 0.011). Limitations of our study include possible misreporting of psoriasis by patients, as well as potential misdiagnosis by clinicians. In addition, there is also limited ethnic variation in the cohorts studied. CONCLUSIONS: Our study, using genetic variants as instrumental variables for BMI, provides evidence that higher BMI leads to a higher risk of psoriasis. This supports the prioritization of therapies and lifestyle interventions aimed at controlling weight for the prevention or treatment of this common skin disease. Mechanistic studies are required to improve understanding of this relationship.
引用
- Budu-Aggrey A, Brumpton B, Tyrrell J, et al. Evidence of a causal relationship between body mass index and psoriasis: A mendelian randomization study. PLoS Med. 2019. PMID: 30703100. doi:10.1371/journal.pmed.1002739
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。